Literature DB >> 11744570

Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debate.

S M Bird.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2001        PMID： 11744570      PMCID： PMC1121868     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Standardization of breast radiotherapy (START) trial. START Trial Management Group.

Authors: 
Journal:  Clin Oncol (R Coll Radiol)       Date:  1999       Impact factor: 4.126

Review 2.  Tamoxifen for the prevention of breast cancer.

Authors:  B Fisher; T J Powles; K J Pritchard
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

3.  Tamoxifen for the prevention of breast cancer. Relationship of trial design to value of data for patient?

Authors:  H Thornton
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 4.  Monitoring clinical trials--interim data should be publicly available.

Authors:  R J Lilford; D Braunholtz; S Edwards; A Stevens
Journal:  BMJ       Date:  2001-08-25

5.  Data sharing in medical research: an empirical investigation.

Authors:  D D Reidpath; P A Allotey
Journal:  Bioethics       Date:  2001-04       Impact factor: 1.898

6.  Methodological issues in AIDS clinical trials. Data monitoring and sequential analysis--an academic perspective.

Authors:  D L DeMets
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.

Authors:  K Dickersin; Y I Min; C L Meinert
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

8.  Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2.

Authors: 
Journal:  Lancet       Date:  1987-02-28       Impact factor: 79.321

9.  The consumer principle of randomisation.

Authors:  S M Gore
Journal:  Lancet       Date:  1994-01-01       Impact factor: 79.321

10.  Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.

Authors:  V Jenkins; L Fallowfield
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640
  10 in total
  1 in total

1.  A prospective, randomized, double-blind, multicenter study comparing remifentanil with fentanyl in mechanically ventilated patients.

Authors:  Claudia Spies; Martin Macguill; Anja Heymann; Christina Ganea; Daniel Krahne; Angelika Assman; Heinrich-Rudolf Kosiek; Kathrin Scholtz; Klaus-Dieter Wernecke; Jörg Martin
Journal:  Intensive Care Med       Date:  2010-12-17       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.